Medtronic PLC (MDT) To Go Ex-Dividend on December 26th

Medtronic PLC (NYSE:MDT) declared a quarterly dividend on Thursday, December 4th. Shareholders of record on Friday, December 26th will be paid a dividend of 0.71 per share by the medical technology company on Friday, January 16th. This represents a c) dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date is Friday, December 26th.

Medtronic has raised its dividend payment by an average of 0.1%annually over the last three years and has increased its dividend every year for the last 49 years. Medtronic has a dividend payout ratio of 47.2% indicating that its dividend is sufficiently covered by earnings. Analysts expect Medtronic to earn $5.83 per share next year, which means the company should continue to be able to cover its $2.84 annual dividend with an expected future payout ratio of 48.7%.

Medtronic Stock Performance

Medtronic stock opened at $97.44 on Wednesday. Medtronic has a twelve month low of $79.29 and a twelve month high of $106.33. The company has a quick ratio of 1.80, a current ratio of 2.42 and a debt-to-equity ratio of 0.57. The company has a market capitalization of $124.92 billion, a P/E ratio of 26.26, a PEG ratio of 2.57 and a beta of 0.71. The stock’s 50 day moving average is $97.44 and its 200 day moving average is $93.61.

Medtronic (NYSE:MDT) last released its earnings results on Tuesday, November 18th. The medical technology company reported $1.36 EPS for the quarter, topping the consensus estimate of $1.31 by $0.05. Medtronic had a return on equity of 14.86% and a net margin of 13.71%.The business had revenue of $8.96 billion for the quarter, compared to the consensus estimate of $8.86 billion. During the same period in the previous year, the company posted $1.26 earnings per share. The company’s revenue for the quarter was up 6.6% compared to the same quarter last year. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. On average, equities research analysts predict that Medtronic will post 5.46 earnings per share for the current fiscal year.

About Medtronic

Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.

Medtronic’s offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).